Rafferty Asset Management, LLC
- SEC CIK
- 0001389426
- Latest filing
- Aug 14, 2026
FDMT holding history
4D Molecular Therapeutics, Inc. in every 13F filed by Rafferty Asset Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
FDMT overviewAll 13F holders of FDMTFull Q2 2026 holdings
- Shares (Q2 2026)
- 44,714
- Value
- $594.7K
- % of portfolio
- <0.1%
- Quarters held
- 13
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 44,714 | $594.7K | <0.1% | −26,682−37.4% | Reduced | Holders |
| Q1 2026 | 71,396 | $664.7K | <0.1% | −12,017−14.4% | Reduced | Holders |
| Q4 2025 | 83,413 | $625.6K | <0.1% | +83,413 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −90,348−100.0% | Sold out | Holders |
| Q3 2024 | 90,348 | $976.7K | <0.1% | −5,217−5.5% | Reduced | Holders |
| Q2 2024 | 95,565 | $2.01M | <0.1% | −96,816−50.3% | Reduced | Holders |
| Q1 2024 | 192,381 | $6.13M | <0.1% | +65,792+52.0% | Added | Holders |
| Q4 2023 | 126,589 | $2.56M | <0.1% | −34,697−21.5% | Reduced | Holders |
| Q3 2023 | 161,286 | $2.05M | <0.1% | −35,869−18.2% | Reduced | Holders |
| Q2 2023 | 197,155 | $3.56M | <0.1% | +62,367+46.3% | Added | Holders |
| Q1 2023 | 134,788 | $2.32M | <0.1% | +86,855+181.2% | Added | Holders |
| Q4 2022 | 47,933 | $1.06M | <0.1% | +47,933 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −71,774−100.0% | Sold out | Holders |
| Q1 2022 | 71,774 | $1.08M | <0.1% | −3,939−5.2% | Reduced | Holders |
| Q4 2021 | 75,713 | $1.66M | <0.1% | +75,713 | New | Holders |